Related by context. All words. (Click for frequent words.) 78 BRCA mutations 78 BRCA2 mutation 75 BRCA1 mutation 75 BRCA2 mutations 75 BRCA1 mutations 74 BRCA2 gene mutation 71 BRCA gene mutation 70 BRCA1 70 ApoE4 gene 70 BRCA gene mutations 69 APOE e4 69 breast cancer gene mutation 69 BRCA 69 BRCA1 gene 68 BRCA2 carriers 67 mutated BRCA1 67 atypical hyperplasia 67 BRCA2 gene 66 HNPCC 66 chlamydial infection 66 ApoE4 66 BRCA2 mutation carriers 65 atypia 65 ε4 65 APOE4 65 elevated CRP 65 TGFBR1 * 6A 65 subclinical hyperthyroidism 65 familial pancreatic cancer 65 BRCA2 gene mutations 65 abnormal Pap test 65 BRCA1 gene mutation 65 KRAS mutations 64 latent TB infection 64 BRCA mutation carriers 64 ApoE4 allele 64 advanced neoplasia 64 colorectal neoplasia 64 advanced adenomas 64 BRCA carriers 63 abnormal mammogram 63 oophorectomy 63 premenopausal 63 BRCA gene 63 APOE ε4 63 BRCA1 mutation carriers 63 hereditary breast cancer 63 endometrial cancers 63 advanced adenoma 63 prophylactic mastectomy 62 testicular germ cell 62 pre cancerous polyps 62 gene mutations 62 placental malaria 62 adenomatous polyps 62 thrombophilia 62 LQTS 62 obstructive coronary artery 62 polycystic ovary syndrome PCOS 62 poorer prognosis 62 TT genotype 62 Li Fraumeni 62 NNRTI resistance 62 latent TB 62 prostate cancer CaP 61 ASCUS 61 EGFR mutation 61 herpes infection 61 BRCA testing 61 APOE genotype 61 APOE gene 61 cervical lesions 61 BRCA2 61 postmenopausal breast cancer 61 BRCA genes 61 irregular menstrual cycles 61 APOE e4 gene 61 preventive mastectomy 61 prostate specific 61 genetic variant 61 PSA velocity 61 operable breast cancer 61 premenopausal breast cancer 61 PCa 61 subclinical hypothyroidism 61 epithelial ovarian cancer 61 TACI mutations 61 folate intake 61 breast cancer susceptibility genes 61 prostate biopsy 61 PTEN mutations 61 poor metabolizers 61 inherited predisposition 61 anovulatory infertility 61 BRAF mutation 61 adenoma 60 HER2 expression 60 inherited mutations 60 mutation 60 CIN2 + 60 CIN3 60 familial adenomatous polyposis 60 IgA deficiency 60 HPV infection 60 Fragile X gene 60 TP# mutation 60 HBsAg 60 gene mutation 60 shorter telomeres 60 HBV infection 60 transferrin saturation 60 familial ALS 60 untreated celiac disease 60 deleterious mutation 60 serum selenium 60 HPV# 60 faulty BRCA2 gene 60 benign breast 60 hydroxyvitamin D levels 60 thyrotropin levels 60 ovarian cancers 60 mutated gene 60 CMV infection 60 hepatitis B infection 60 gallstone disease 60 nonmelanoma skin cancers 60 intestinal polyps 60 breast cancer genes BRCA1 60 lymph node involvement 60 chromosomal abnormalities 60 noncarriers 60 sentinel nodes 60 axillary lymph nodes 60 abnormal pap smear 60 V Leiden 60 screening colonoscopy 60 gene variant 60 HNSCC 60 SE alleles 60 testosterone supplementation 60 PSA screening 60 EGFR mutations 60 EBV infection 60 G#S mutation 60 APOE allele 60 atypical ductal hyperplasia 60 estrogen receptor ER 60 invasive carcinoma 60 Schaffir 60 CYP#C# [001] 60 histological subtype 60 asymptomatic 60 adiponectin levels 59 PTEN mutation 59 #q# deletion 59 precancerous cervical lesions 59 subclinical atherosclerosis 59 polyp recurrence 59 serum IgE 59 SHBG levels 59 preventive mastectomies 59 BCG vaccinated 59 p# mutations 59 HPV infections 59 mtDNA mutations 59 microscopic hematuria 59 coinfection 59 chlamydia infection 59 GBV C 59 estrogen receptor negative 59 micrometastases 59 proband 59 elevated triglyceride levels 59 bowel polyps 59 AAT deficiency 59 Ovary removal 59 K ras mutations 59 recurrent UTI 59 germline mutations 59 subclinical 59 spontaneous preterm delivery 59 coronary calcification 59 penetrance 59 estrogen receptor positive 59 spontaneous preterm birth 59 genes BRCA1 59 prophylactic mastectomies 59 tuberculin skin testing 59 HIV HCV coinfected 59 HER2 positive cancers 59 MYH9 gene 59 oropharyngeal cancer 59 HER2 positive tumors 59 MSH2 59 VUR 59 precancerous cervical 59 mutated K ras 59 serum PSA 59 Hurthle cell 59 KRAS mutation 59 latent tuberculosis infection 59 BRAC2 59 RhD negative 59 thyroid hormone levels 59 LTBI 59 narcolepsy cataplexy 59 KIF6 gene variant 59 Adjuvant chemotherapy 59 primary ovarian insufficiency 59 gene predisposing 59 polycystic ovary syndrome 59 pCR 59 endometrial carcinoma 59 premature menopause 59 cerebral microbleeds 59 undergone hysterectomy 59 basal cell nevus syndrome 59 HPV 59 MGUS 59 UGT#A# * 59 tamoxifen therapy 58 HCV antibody 58 EGFR mutation status 58 deleterious mutations 58 ovarian tumors 58 genetic abnormalities 58 ovaries removed 58 BRCA2 genetic mutations 58 genetic mutations 58 breast cancer gene mutations 58 coronary artery calcium 58 lobular breast cancer 58 probands 58 tumor histology 58 gestational diabetes mellitus 58 abnormal Pap smear 58 CC genotype 58 dose ionizing radiation 58 BMPR2 58 herpesviruses 58 genetic variants associated 58 aneuploidy 58 carotid stenosis 58 contralateral breast cancer 58 MetS 58 abnormal Pap smears 58 K ras mutation 58 recurrent miscarriages 58 renal cell carcinomas 58 TCF#L# gene 58 gene BRCA2 58 BRAF V#E mutation 58 ADPKD 58 HER2 negative 58 mammographic density 58 autoantibodies 58 neuroblastoma tumors 58 specific antigen 58 SLNB 58 ovarian hormones 58 #.#ng/ml 58 HGPIN 58 antigen PSA 58 hormone receptor negative 58 anal cancers 58 HBV 58 chorioamnionitis 58 lobular involution 58 Prostate Specific Antigen PSA 58 nonpregnant women 58 recurrent miscarriage 58 D dimer 58 peritoneal cancer 58 germline mutation 58 thyroid nodules 58 prenatal diagnosis 58 abnormal cytology 58 abnormal mammograms 58 sporadic ALS 58 chromosomal alterations 58 microdeletions 58 APOE 57 precancer 57 HER2 overexpression 57 benign proliferative breast 57 pre menopausal 57 telomere lengths 57 heterozygous 57 breast cancers 57 hereditary predisposition 57 CYP#D# genotype 57 elevated LDL cholesterol 57 gene variants 57 endometrial hyperplasia 57 CHEK2 57 invasive cervical cancer 57 GSTM1 gene 57 ABCB1 57 mutations 57 seropositivity 57 MYCN amplification 57 fetal malformations 57 curable cancers 57 pre eclamptic 57 postmenopausal hormones 57 Hashimoto thyroiditis 57 genes predisposing 57 parous women 57 lobular cancer 57 baseline mammogram 57 Klinefelter syndrome 57 estrogen progestin therapy 57 virologic failure 57 clinically insignificant 57 Rh positive 57 Hepatitis B virus 57 menopausal hormone therapy 57 invasive breast cancer 57 G allele 57 testicular tumors 57 NAFLD 57 extracolonic findings 57 Cristofanilli 57 gene variation 57 abnormal Pap 57 variant alleles 57 precancerous polyp 57 ductal breast cancer 57 prostate adenocarcinoma 57 antiphospholipid antibodies 57 anal HPV 57 carotid plaque 57 colorectal polyps 57 GBA mutations 57 postmenopausal 57 genetic variants 57 HLA B# 57 sCJD 57 FGFR2 57 vertebral fracture 57 GnRH agonists 57 endometrial cancer 57 2D 4D ratio 57 CAG repeats 57 HbF 57 APOE4 gene 57 HLA B 57 Epstein Barr virus EBV 57 elevated depressive symptoms 57 intensive statin therapy 57 genetic polymorphisms 57 anti HBs 57 folate supplementation 57 BRCA1 BRCA2 57 MLH1 57 mosaicism 57 adrenal function 57 bilateral oophorectomy 57 apolipoprotein E gene 57 Heavy menstrual bleeding 57 hormone therapy estrogen 57 precursor lesions 57 mutant allele 57 varicocele 57 JAK2 mutation 57 defective gene 57 Recurrence Score 57 cTnT 57 elevated triglycerides 57 PALB2 57 GSTT1 57 antenatal depression 57 Dr Zorbas 57 ovarian cancer 56 axillary dissection 56 distant metastases 56 lymph node biopsies 56 colorectal cancer CRC 56 homozygous 56 cranial irradiation 56 postoperative delirium 56 seronegative 56 Ashkenazi Jewish 56 BRCA2 breast cancer 56 MTHFR 56 H. pylori 56 KIF6 gene 56 tibolone 56 breast endometrial 56 serum testosterone levels 56 cervical HPV 56 GBM tumors 56 PCA3 scores 56 slow metabolizers 56 preterm delivery 56 FeNO 56 psychiatric comorbidity 56 familial hypercholesterolemia 56 bowel cancers 56 screening mammogram 56 low expressors 56 deCODE BreastCancer TM 56 genital HPV infection 56 lymph node metastases 56 CCR5 delta# 56 adjuvant radiation 56 selenium intake 56 chromosomal disorders 56 prenatally diagnosed 56 breast lesions 56 diffuse gastric 56 CYP#D# 56 faulty BRCA1 gene 56 HER2 gene 56 HPV genotypes 56 venous thrombosis 56 pancreatic adenocarcinoma 56 subfertility 56 HCV infected 56 PTPN# 56 genotype 56 gynecologic malignancy 56 androgen deficiency 56 autistic traits 56 virological failure 56 Apolipoprotein E4 56 precancers 56 malignancy 56 HER2 amplification 56 polycystic ovarian syndrome PCOS 56 hereditary nonpolyposis colorectal cancer 56 lung adenocarcinoma 56 platelet reactivity 56 undetectable PSA 56 recessive mutations 56 colorectal cancer 56 bilirubin levels 56 APOC3 56 CYP#D# gene 56 FTO variant 56 asymptomatic PAD 56 Rh negative 56 colorectal neoplasms 56 axillary nodes 56 liver transplant recipients 56 heterozygous FH 56 diagnosed prenatally 56 FGFR2 gene 56 asymptomatically 56 Asymptomatic 56 somatic mutations 56 heterozygotes 56 Leitzmann 56 prostate cancers 56 NAbs 56 SHBG 56 chromosomal defects 56 bacterial vaginosis 56 perimenopausal women 56 recurrent VTE 56 serous ovarian cancer 56 autoimmune thyroid 56 nonfasting triglyceride levels 56 dysglycemia 56 lobular carcinoma 56 MAOA L 56 thiopurine 56 anti JCV antibodies 56 hereditary hemochromatosis 55 breast carcinomas 55 ovarian carcinoma 55 genetic mutation 55 chlamydia sexually transmitted 55 chromosomal instability 55 ApoE gene 55 undergoing radical prostatectomy 55 Wwox 55 serum testosterone 55 mutated BRAF gene 55 intravenous bisphosphonates 55 T1DM 55 colon polyps 55 undergo colonoscopy 55 invasive ductal 55 grade cervical intraepithelial 55 chromosomal aberrations 55 shorter telomere length 55 GISTs 55 microalbuminuria 55 cognitively normal 55 baseline HbA1c 55 gestational diabetes 55 CDH1 55 carbohydrate intolerance 55 tanned indoors 55 prescribed statins 55 unexplained infertility 55 CDKN2A 55 renal carcinoma 55 microvascular disease 55 Chlamydia infection 55 cervical carcinoma 55 gestational hypertension 55 Subgroup analyzes 55 adjuvant radiotherapy 55 microsatellite instability 55 alleles 55 troponin T 55 statin medications 55 KRAS status 55 undergo prostate biopsy 55 serum uric acid 55 plasma folate 55 HCV infection 55 apolipoprotein E 55 prostate pancreatic 55 NP CRNs 55 axillary node dissection 55 EUS FNA 55 ultra rapid metabolizer 55 cervical intraepithelial neoplasia 55 tumor subtypes 55 carotid plaques 55 faulty BRCA genes 55 ARVD 55 EpCAM expression 55 urate levels 55 colorectal adenoma 55 lupus anticoagulant 55 susceptibility gene 55 colorectal cancers 55 fetuin 55 premature ovarian 55 mild gestational diabetes 55 ApoE 55 spontaneous mutations 55 axillary node 55 adnexal mass 55 unmeasured factors 55 immunodeficient 55 benign lesions 55 chronic prostatitis 55 chronic HBV 55 HIV seronegative 55 TP# mutations 55 Rh factor 55 genital ulcer disease 55 Squamous 55 untreated sleep apnea 55 antioxidant supplementation 55 incidentalomas 55 cervical neoplasia 55 urethritis 55 asymptomatic carotid stenosis 55 genotyped 55 salpingo oophorectomy 55 apolipoprotein E4 55 gastric adenocarcinoma 55 serostatus 55 metastatic prostate 55 ductal cancer 55 premenopausal women 55 hematopoietic cancers 55 mitochondrial mutations 55 rheumatoid factor 55 apoC III 55 IUGR 55 airway responsiveness 55 type 1diabetes 55 uterine cancers 55 p# mutation 55 allele 55 urine cytology 55 G6PD deficiency 55 thyroid stimulating hormone 55 varicoceles 55 folate deficiency 55 HIV seropositive 55 genetic predisposition 55 mutated BRCA 55 fetal chromosomal 55 HPV subtypes 55 precancerous condition 55 esophageal squamous cell carcinoma 55 osteopenia 55 genital HPV infections 55 breast cancer recurrences 55 thyrotropin 55 benign polyps 55 invasive ductal breast cancer 55 coinfected 55 chlamydial 55 neoplasias 55 ovarian endometrial 55 breast cancer recurrence 55 warfarin dose 55 bladder cancers 55 AVODART 55 sonographic diagnosis 55 hereditary breast 55 fasting triglyceride levels 55 genotypic resistance 55 ERCC1 55 CaP 55 nonvertebral fracture 55 BRAF mutations 55 colorectal adenomas 55 TB germ 55 colon cancers 55 serum urate levels 55 GSTM1 55 missense mutations 54 colon tumors 54 Colon polyps 54 genital tract 54 T2DM 54 Multivariate analyzes 54 catheter angiography 54 carry BRCA mutation 54 2 diabetes T2D 54 abnormal glucose tolerance 54 nondiabetic 54 BARD1 54 Seewaldt 54 BMI percentile 54 folate intakes 54 elevated LDH 54 hormone deprivation 54 serum IGF 54 specific antigen PSA 54 homocysteine concentrations 54 leukaemias 54 invasive prenatal 54 nodal metastasis 54 urinary symptoms 54 diabetes mellitus DM 54 digital rectal examination 54 chromosomal anomalies 54 Her2/neu 54 distal colon cancer 54 NOMID 54 K#R [002] 54 elevated homocysteine 54 beta blocker therapy 54 undergone hysterectomies 54 cystatin C 54 hsCRP levels 54 ovarian hyperstimulation 54 hormonal therapy 54 multivariate analyzes 54 CIN3 + 54 lymph node removal 54 antiviral therapy 54 prediabetes 54 variant allele 54 oral bisphosphonates 54 NNRTIs 54 neoplasia 54 genetic abnormality 54 cervical abnormalities 54 late onset hypogonadism 54 HIV uninfected 54 APOL1 54 asymptomatic carriers 54 preeclamptic 54 pneumococci 54 hepatitis C genotype 54 serum concentrations 54 allele frequencies 54 biochemical recurrence 54 adjuvant hormonal therapy 54 estrogen metabolites 54 biochemical relapse 54 Li Fraumeni syndrome 54 LRRK2 mutations 54 adenomas 54 serum creatinine levels 54 HbA1C 54 VKORC1 54 postexposure prophylaxis 54 Uterine cancer 54 abnormal vaginal bleeding 54 hormone receptor positive 54 antibody titer 54 T#I [002] 54 urate 54 Amniocentesis 54 fasting glucose levels 54 lipid lowering therapy 54 untreated chlamydia 54 coronary artery calcification 54 oncogenic HPV 54 telomere length 54 denser breasts 54 antihypertensive medication 54 oropharyngeal cancers 54 DCIS 54 susceptibility genes 54 immunosuppressant therapy 54 TCF#L# 54 prehypertensive 54 nonmelanoma skin cancer 54 MCAD deficiency 54 nonseminoma 54 neural tube defect 54 AUDs 54 pathogenic mutations 54 beta carotene supplements 54 HBeAg negative 54 epigenetic changes 54 initiating HAART 54 thalassemia trait 54 neurocognitive impairment 54 malignant lesions 54 preterm deliveries 54 sentinel node 54 Multivariate analysis 54 comorbidities 54 e4 allele 54 HER2 receptor 54 albumin excretion 54 Cowden syndrome 54 HER2 54 K ras gene 54 APOE epsilon 4 54 contralateral breast 54 uveal melanoma 54 MHC molecules 54 tumor recurrence 54 genital ulcers 54 malignant neoplasm 54 BRAF V#E 54 abnormal pap smears 54 hypovitaminosis D 54 endometrial thickness 54 mutated genes 54 de novo mutations 54 PITX2 54 symptomatic fibroids 54 cardioembolic stroke 54 MnSOD 54 surgical biopsy 54 PARP inhibition 54 serum calcium 54 B7 H3 54 ovarian malignancy 54 MCADD 54 relapsed ALL 54 singleton pregnancy 54 genital HPV 54 disease NAFLD 54 colorectal polyp 54 uncontrolled asthma 54 HLA gene variant 54 genetic susceptibility 54 molecular abnormalities 54 baseline LDH 54 undergoing bariatric surgery 54 LV dysfunction 54 M#V mutation 54 breast ovarian 54 MRSA colonization 54 trichomonas 54 androgen deprivation 54 PCNSL 54 HBeAg 54 lymphocyte count 54 sigmoidoscopy 54 aneuploidies 54 neurodevelopmental outcomes 54 HG PIN 54 confounding variables 54 untreated hypothyroidism 54 asymptomatic hypothyroidism 54 folic acid intake 54 CIN2 54 homozygotes 54 acrylamide intake 54 HER2 positive 54 Genetic variants 54 oestradiol 54 seroconverted 54 paternal lineage 54 colon rectal 54 subclinical disease 54 C#Y 54 chromosome abnormality 54 herpes zoster vaccine 54 undergone radical prostatectomy 54 postmenopausal hormone 54 yearly mammograms 54 superinfection 54 glycated hemoglobin levels 54 Pischon 54 serologic testing 54 BRCA breast cancer 54 anal lesions 54 Epidemiologic studies 54 hyperandrogenism 54 nestin 53 lipid abnormalities 53 WNV infection 53 GIST tumors 53 PSADT 53 genital tract infections 53 amniocentesis 53 Inhibin B 53 serum vitamin D 53 polycystic ovarian syndrome 53 tamoxifen 53 impair fertility 53 grade cervical dysplasia 53 dysfunctional voiding 53 Cholangiocarcinoma 53 cTnT levels 53 carotid IMT 53 PTEN gene 53 immunocompetent 53 metabolic syndrome MetS 53 distant metastasis 53 FTO gene 53 body fatness 53 BRCA2 genes 53 colonoscopy screenings 53 breast carcinoma 53 C. trachomatis 53 chromosomal regions 53 hypogonadal 53 female endoscopist 53 Pap smear 53 CYP#C# * 53 atopic 53 XMRV infection 53 chronic HBV infection 53 prostate cancer PCa 53 Lp PLA2 53 postoperative pulmonary 53 metastatic gastric 53 homocysteine levels 53 unmeasured confounders 53 situ LCIS 53 colorectal tumor 53 chromosomal anomaly 53 chlamydia infections 53 spontaneous preterm births 53 Prehypertension 53 drank decaffeinated coffee 53 serologic 53 arterial thickening 53 silent myocardial ischemia 53 renal toxicity 53 serum estradiol 53 heterozygote 53 FMR1 gene 53 Genetic predisposition 53 cryptorchidism 53 fructose diet 53 gene APOE 53 beta carotene supplementation 53 nodal metastases 53 estrogen receptor 53 IDH mutations 53 estrogen therapy 53 abdominal adiposity 53 intestinal biopsy 53 precancerous tumors 53 fibroids endometriosis 53 vitamin D inadequacy 53 ALND 53 SLN biopsy 53 azoospermia 53 univariate analyzes 53 nonischemic 53 nonalcoholic steatohepatitis NASH 53 Prostatitis 53 fluoroquinolone resistance 53 prostate carcinoma 53 uterine ovarian 53 HPV prevalence 53 HCV genotype 53 abnormal lipid 53 pancreatic cancers 53 postnatally 53 antihypertensive therapy 53 esophageal cancers 53 obstructive CAD 53 RBP4 53 lipid levels 53 elevated bilirubin 53 prognostic markers 53 hydroxychloroquine 53 progestins 53 receptive anal sex 53 born preterm 53 progesterone receptor negative 53 HLA genes 53 BRIP1 53 SIDS infants 53 intra abdominal fat 53 Framingham Offspring Study 53 acute leukemias 53 colorectal tumors 53 chorionic villus sampling 53 multivariate logistic regression 53 Flexi Scope 53 lipoprotein 53 clinically detectable 53 undergoing hysterectomy 53 MTHFR gene 53 carcinoid tumors 53 familial predisposition 53 noncancerous prostate 53 lymphoproliferative disorders 53 psychiatric comorbidities 53 abnormal cervical 53 node metastases 53 thyroglobulin 53 serum ferritin 53 CGG repeats 53 genetic trait 53 colorectal carcinoma 53 Testicular cancer 53 KRAS oncogene 53 colorectal cancer incidence 53 mammographically 53 modifiable risk 53 Pap smear screening 53 invasive lobular carcinoma 53 toxoplasma 53 genomewide 53 BRCA deficient 53 osteoporotic fracture 53 BRAF gene 53 rs# [001] 53 serum lipid levels 53 oesophageal adenocarcinoma 53 CMV disease 53 Folic acid supplements 53 serum calcium levels 53 cisplatin chemotherapy 53 de ath 53 MSMB 53 TRAF1 C5 53 postmenopausal hormone therapy 53 aminotransferase levels 53 colorectal carcinomas 53 STAT4 53 leiomyomas 53 choline intake 53 autoantibody positive 53 HLA DQ2 53 preoperative PSA 53 organophosphate exposure 53 mesotheliomas 53 Vitamin D insufficiency 53 metastatic melanomas 53 CARDIA 53 elevated LDL 53 conjugated equine estrogen 53 haptoglobin 53 preeclampsia 53 prostate biopsies 53 polycystic ovaries 53 IKZF1 53 acute myelogenous leukemia AML 53 HPV types 53 NPY expression 53 endometrial 53 CVD mortality 53 MAGE A3 protein 53 locoregional recurrence 53 lipid lowering medications 53 OPRM1 gene 53 pathologic fractures 53 overdiagnosis 53 myeloid leukemia 53 familial clustering 53 placenta accreta 53 antidiabetic medication 53 abnormal Pap tests 53 venous thromboembolism 53 familial aggregation 53 RLS sufferers 53 GPC5 53 recurrent ovarian cancer 53 prenatal testosterone 53 systemic lupus erythematosus SLE 53 AML MDS 53 carotid bruit 53 abnormal lipid levels 53 hsCRP 53 undiagnosed celiac disease 53 endoxifen 53 malignant polyps 53 premenstrual syndrome PMS 53 Acute myeloid leukemia 53 pleural mesothelioma 53 overexpress HER2 53 Haptoglobin